FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804058066> ?p ?o ?g. }

• W2804058066 endingPage "3916" @default.
• W2804058066 startingPage "3908" @default.
• W2804058066 abstract "Purpose: Currently, no genomic signature exists to distinguish men most likely to progress on adjuvant androgen deprivation therapy (ADT) after radical prostatectomy for high-risk prostate cancer. Here we develop and validate a gene expression signature to predict response to postoperative ADT.Experimental Design: A training set consisting of 284 radical prostatectomy patients was established after 1:1 propensity score matching metastasis between adjuvant-ADT (a-ADT)-treated and no ADT-treated groups. An ADT Response Signature (ADT-RS) was identified from neuroendocrine and AR signaling-related genes. Two independent cohorts were used to form three separate data sets for validation (set I, n = 232; set II, n = 435; set III, n = 612). The primary endpoint of the analysis was postoperative metastasis.Results: Increases in ADT-RS score were associated with a reduction in risk of metastasis only in a-ADT patients. On multivariable analysis, ADT-RS by ADT treatment interaction term remained associated with metastasis in both validation sets (set I: HR = 0.18, Pinteraction = 0.009; set II: HR = 0.25, Pinteraction = 0.019). In a matched validation set III, patients with Low ADT-RS scores had similar 10-year metastasis rates in the a-ADT and no-ADT groups (30.1% vs. 31.0%, P = 0.989). Among High ADT-RS patients, 10-year metastasis rates were significantly lower for a-ADT versus no-ADT patients (9.4% vs. 29.2%, P = 0.021). The marginal ADT-RS by ADT interaction remained significant in the matched dataset (Pinteraction = 0.035).Conclusions: Patients with High ADT-RS benefited from a-ADT. In combination with prognostic risk factors, use of ADT-RS may thus allow for identification of ADT-responsive tumors that may benefit most from early androgen blockade after radical prostatectomy. We discovered a gene signature that when present in primary prostate tumors may be useful to predict patients who may respond to early ADT after surgery. Clin Cancer Res; 24(16); 3908-16. ©2018 AACR." @default.
• W2804058066 created "2018-06-01" @default.
• W2804058066 creator A5000697093 @default.
• W2804058066 creator A5001069772 @default.
• W2804058066 creator A5005828452 @default.
• W2804058066 creator A5006595036 @default.
• W2804058066 creator A5008552473 @default.
• W2804058066 creator A5010930816 @default.
• W2804058066 creator A5012794522 @default.
• W2804058066 creator A5013881851 @default.
• W2804058066 creator A5014582211 @default.
• W2804058066 creator A5015096941 @default.
• W2804058066 creator A5019770974 @default.
• W2804058066 creator A5020006331 @default.
• W2804058066 creator A5030221990 @default.
• W2804058066 creator A5032201078 @default.
• W2804058066 creator A5039646183 @default.
• W2804058066 creator A5042227397 @default.
• W2804058066 creator A5044704274 @default.
• W2804058066 creator A5049018134 @default.
• W2804058066 creator A5049788241 @default.
• W2804058066 creator A5057587736 @default.
• W2804058066 creator A5060720802 @default.
• W2804058066 creator A5067282152 @default.
• W2804058066 creator A5076238068 @default.
• W2804058066 creator A5076512965 @default.
• W2804058066 creator A5076810623 @default.
• W2804058066 creator A5089925113 @default.
• W2804058066 date "2018-08-14" @default.
• W2804058066 modified "2023-10-15" @default.
• W2804058066 title "Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy" @default.
• W2804058066 cites W1508662657 @default.
• W2804058066 cites W1539602051 @default.
• W2804058066 cites W1542345927 @default.
• W2804058066 cites W1904333099 @default.
• W2804058066 cites W1949146490 @default.
• W2804058066 cites W1972298018 @default.
• W2804058066 cites W1973836296 @default.
• W2804058066 cites W1998343146 @default.
• W2804058066 cites W2000056288 @default.
• W2804058066 cites W2001994418 @default.
• W2804058066 cites W2033661476 @default.
• W2804058066 cites W2038981426 @default.
• W2804058066 cites W2072903300 @default.
• W2804058066 cites W2081375228 @default.
• W2804058066 cites W2086655570 @default.
• W2804058066 cites W2094252220 @default.
• W2804058066 cites W2102818606 @default.
• W2804058066 cites W2119776733 @default.
• W2804058066 cites W2123664981 @default.
• W2804058066 cites W2128521057 @default.
• W2804058066 cites W2130955565 @default.
• W2804058066 cites W2140435154 @default.
• W2804058066 cites W2144167673 @default.
• W2804058066 cites W2144168223 @default.
• W2804058066 cites W2144312415 @default.
• W2804058066 cites W2150291618 @default.
• W2804058066 cites W2224702980 @default.
• W2804058066 cites W2530065228 @default.
• W2804058066 cites W2538040847 @default.
• W2804058066 cites W2567986926 @default.
• W2804058066 cites W2591558565 @default.
• W2804058066 cites W893557411 @default.
• W2804058066 doi "https://doi.org/10.1158/1078-0432.ccr-17-2745" @default.
• W2804058066 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6512950" @default.
• W2804058066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29760221" @default.
• W2804058066 hasPublicationYear "2018" @default.
• W2804058066 type Work @default.
• W2804058066 sameAs 2804058066 @default.
• W2804058066 citedByCount "22" @default.
• W2804058066 countsByYear W28040580662018 @default.
• W2804058066 countsByYear W28040580662019 @default.
• W2804058066 countsByYear W28040580662020 @default.
• W2804058066 countsByYear W28040580662021 @default.
• W2804058066 countsByYear W28040580662022 @default.
• W2804058066 countsByYear W28040580662023 @default.
• W2804058066 crossrefType "journal-article" @default.
• W2804058066 hasAuthorship W2804058066A5000697093 @default.
• W2804058066 hasAuthorship W2804058066A5001069772 @default.
• W2804058066 hasAuthorship W2804058066A5005828452 @default.
• W2804058066 hasAuthorship W2804058066A5006595036 @default.
• W2804058066 hasAuthorship W2804058066A5008552473 @default.
• W2804058066 hasAuthorship W2804058066A5010930816 @default.
• W2804058066 hasAuthorship W2804058066A5012794522 @default.
• W2804058066 hasAuthorship W2804058066A5013881851 @default.
• W2804058066 hasAuthorship W2804058066A5014582211 @default.
• W2804058066 hasAuthorship W2804058066A5015096941 @default.
• W2804058066 hasAuthorship W2804058066A5019770974 @default.
• W2804058066 hasAuthorship W2804058066A5020006331 @default.
• W2804058066 hasAuthorship W2804058066A5030221990 @default.
• W2804058066 hasAuthorship W2804058066A5032201078 @default.
• W2804058066 hasAuthorship W2804058066A5039646183 @default.
• W2804058066 hasAuthorship W2804058066A5042227397 @default.
• W2804058066 hasAuthorship W2804058066A5044704274 @default.
• W2804058066 hasAuthorship W2804058066A5049018134 @default.
• W2804058066 hasAuthorship W2804058066A5049788241 @default.
• W2804058066 hasAuthorship W2804058066A5057587736 @default.
• W2804058066 hasAuthorship W2804058066A5060720802 @default.

• next